Paclitaxel (PTX), as a diterpenoid alkaloid exhibiting anti-cancer properties, it has the ability to reverse AEC’s EMT, enhance miR-140 expression, suppress Smad3 and p-Smad3, and elevate E-cadherin levels. This evidence concerns the gene SMAD3 and cancer.